- Home
- INDP vs NCRA Comparison
INDP vs NCRA Comparison
Compare INDP & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- NCRA
- Stock Information
- Founded
- INDP 2000
- NCRA 2002
- Country
- INDP United States
- NCRA Taiwan
- Employees
- INDP N/A
- NCRA N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- INDP Health Care
- NCRA Consumer Staples
- Exchange
- INDP Nasdaq
- NCRA Nasdaq
- Market Cap
- INDP 8.8M
- NCRA 11.7M
- IPO Year
- INDP N/A
- NCRA N/A
- Fundamental
- Price
- INDP $0.79
- NCRA $0.95
- Analyst Decision
- INDP Strong Buy
- NCRA
- Analyst Count
- INDP 2
- NCRA 0
- Target Price
- INDP $8.50
- NCRA N/A
- AVG Volume (30 Days)
- INDP 19.4K
- NCRA 40.2K
- Earning Date
- INDP 03-17-2025
- NCRA 01-01-0001
- Dividend Yield
- INDP N/A
- NCRA N/A
- EPS Growth
- INDP N/A
- NCRA N/A
- EPS
- INDP N/A
- NCRA N/A
- Revenue
- INDP N/A
- NCRA $20,483,694.00
- Revenue This Year
- INDP N/A
- NCRA N/A
- Revenue Next Year
- INDP N/A
- NCRA N/A
- P/E Ratio
- INDP N/A
- NCRA N/A
- Revenue Growth
- INDP N/A
- NCRA N/A
- 52 Week Low
- INDP $0.70
- NCRA $0.70
- 52 Week High
- INDP $3.10
- NCRA $2.09
- Technical
- Relative Strength Index (RSI)
- INDP 48.01
- NCRA 53.47
- Support Level
- INDP $0.76
- NCRA $0.90
- Resistance Level
- INDP $0.86
- NCRA $0.99
- Average True Range (ATR)
- INDP 0.06
- NCRA 0.05
- MACD
- INDP 0.01
- NCRA 0.01
- Stochastic Oscillator
- INDP 69.81
- NCRA 72.22
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.